First-in-Class Clinical Pharmacology
Phase I/IIa Early Clinical Development
Early phase clinical research, including special population and adaptive trials are conducted at our upscale clinical pharmacology unit. Successful recruitment of healthy normal subjects and intent–to-treat populations is ensured secondary to our extensive therapeutic area database and experience gained from later stage studies conducted over the last decade. The upscale, purpose-built research campus is highlighted as a “Center of Research Excellence” with a tradition of rapid study start-up, successful subject recruitment and superior data quality.

On average, our dedicated full-time experienced Principal Investigators have participated in approximately 200 clinical trials each, alongside our team of > 50 clinical research professionals.

Phase I/IIa Clinical Pharmacology Unit

Facility
  • 80-bed secure upscale facility
  • First-in-Human (FIH) unit equipped with telemetry for intense cardiac monitoring
  • Configurable, separate male and female wards
  • Pharmacy and drug storage: Secure, temperature-controlled drug storage, dispensing and preparation pharmacy
  • On-site extemporaneous drug preparation room with negative pressure
  • Menus designed by Registered Dieticians and catered meals prepared to protocol specifications
  • Courtesy telephones, private lockers and laundry facilities for personal belongings
  • Push-button emergency devices in bathrooms and dorm rooms
  • Catered menus prepared to protocol specifications
  • Central IRB site or Local IRB utilization
Security
  • Closed-circuit TV and secure key code access
  • Central Monitoring Station for 24-hour subject observation
  • Push-button emergency devices in bathrooms and dorm rooms
  • Back-up generator
Subject Amenities
  • Extensive subject entertainment facilities: plasma televisions, theater room with movie style seating, full arcade, and computer/Internet area
  • Courtesy telephones, private lockers and laundry facilities for personal belongings
  • Private bathrooms and shower facilities, ensuring subject retention
Capabilities

Study Types
  • Intent-to-Treat populations:
    Proof of Concept
  • Drug Interaction
  • Drug Metabolism
  • Bioavailability
  • Bioequivalence
  • Dose-ranging and Tolerability
  • Pharmacokinetic
  • Pharmacodynamic
  • Cardiac Safety
  • First in Human
  • ACLS Certified Paramedics and Physicians on staff
Therapeutic Areas
  • CNS
  • Psychiatry
  • Vaccines
  • Pulmonary
  • Addiction
  • Metabolic
  • Pain
  • Dermatology
  • Sleep
Populations
  • Psychiatry
  • Sleep Disorders
  • Pediatric
  • Adolescent
  • Elderly
  • Obesity
  • Diabetes
  • Dermatology
  • Women’s Studies
  • Others upon Request
Administration Routes
  • IV, IM and Subcutaneous Injection
  • Inhaled
  • Intranasal
  • Oral, Sublingual
  • Ophthalmic
  • Buccal
  • Topical
  • Transdermal
  • Suppository

Full-Service Options

Vince and Associates provides full support options including:
  • Project Management
  • Medical Writing
  • Monitoring
  • Data Management
  • Biostatistics
  • PK Analysis

Please contact Dr. Lorraine M. Rusch at LRusch@vinceandassociates.com or 914-548-1690.
Headquarters: 10103 Metcalf Ave. | Overland Park, KS 66212 | Office: 913.696.1601 | Fax: 913.696.1640
Privacy Statement | Site Map | ©2011 All Rights Reserved, Vince and Associates Clinical Research